Product
TTAX03
Aliases
TTAX03 10mg, TTAX03 25mg
2 clinical trials
4 indications
Indication
Facet Joint PainIndication
Osteoarthritis, KneeIndication
Chronic Knee PainIndication
ArthritisClinical trial
A Randomized, Phase 1 Dose Finding Study of TTAX03 for the Treatment of Lumbosacral Facet Joint PainStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Clinical trial
A Phase 2, 52-Week Trial of TTAX03 vs. Saline as a Single Intra-articular Injection in Kellgren-Lawrence Grade 3-4 Knee OAStatus: Active (not recruiting), Estimated PCD: 2024-07-19